AKTX

Akari Therapeutics

11 hedge funds and large institutions have $11.5M invested in Akari Therapeutics in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Franklin Resources
1
Franklin Resources
California
$3.37M 701,754
BBA
2
Baker Bros. Advisors
New York
$3.24M 673,887
BC
3
Broadfin Capital
New York
$2.26M 470,877
CAM
4
Cormorant Asset Management
Massachusetts
$1.44M 300,000 +55,500 +23%
SCM
5
Sio Capital Management
New York
$881K 183,505 +183,505 New
DCM
6
DAFNA Capital Management
California
$211K 43,900
HighTower Advisors
7
HighTower Advisors
Illinois
$66K 13,742 -15,658 -53%
TRCT
8
Tower Research Capital (TRC)
New York
$3K 532 +280 +111%
SM
9
Sabby Management
Florida
$2.59K 538,703 -321,750 -37%
Citigroup
10
Citigroup
New York
$1K 300 +300 New
PCM
11
Prelude Capital Management
New York
-2,400 Closed
Morgan Stanley
12
Morgan Stanley
New York
$0 7